New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
Authors
Keywords
Cushing’s disease, Pituitary corticotroph adenoma, Somatostatin analog, Cabergoline, Pasireotide, Retinoic acid
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 114, Issue 1, Pages 1-11
Publisher
Springer Nature
Online
2013-05-15
DOI
10.1007/s11060-013-1151-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Temozolomide in aggressive pituitary adenomas and carcinomas
- (2012) LD Ortiz et al. Clinics
- Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
- (2012) Camille Baudry et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Differential Expression of Somatostatin Receptor Subtype 1–5 Proteins in Numerous Human Normal Tissues
- (2012) N. Unger et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Potential Role for Retinoic Acid in Patients with Cushing's Disease
- (2012) Francesca Pecori Giraldi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
- (2012) Maria Fleseriu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Medical Management of Persistent and Recurrent Cushing Disease
- (2012) Maria Fleseriu NEUROSURGERY CLINICS OF NORTH AMERICA
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Medical management of Cushing’s disease: what is the future?
- (2012) Maria Fleseriu et al. Pituitary
- The Calcium-Sensing Receptor: A Molecular Perspective
- (2011) Aaron L. Magno et al. ENDOCRINE REVIEWS
- DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours
- (2011) U Plöckinger et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
- (2011) Hidenori Fukuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of SOM230 (Pasireotide) on Corticotropic Cells: Action in Dogs with Cushing’s Disease
- (2011) Victor Castillo et al. NEUROENDOCRINOLOGY
- Efficacy of Cabergoline in Uncured (Persistent or Recurrent) Cushing Disease After Pituitary Surgical Treatment with or without Radiotherapy
- (2010) Anurag Lila et al. Endocrine Practice
- Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases
- (2010) Marco Losa et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cabergoline monotherapy in the long-term treatment of Cushing's disease
- (2010) Ariane Godbout et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- SOM230 (Pasireotide) and Temozolomide Achieve Sustained Control of Tumour Progression and ACTH Secretion in Pituitary Carcinoma with Widespread Metastases
- (2010) H. Bode et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
- (2010) Zachary M. Bush et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Epidemiology of Cushing’s Syndrome
- (2010) Charlotte Steffensen et al. NEUROENDOCRINOLOGY
- Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
- (2010) Richard A. Feelders et al. NEW ENGLAND JOURNAL OF MEDICINE
- Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
- (2010) Troy H. Dillard et al. Pituitary
- Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
- (2010) Beverly MK Biller et al. BMC Endocrine Disorders
- Merits and pitfalls of mifepristone in Cushing's syndrome
- (2009) F Castinetti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
- (2008) F Castinetti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly
- (2008) Robert D. Murray et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Aortic Valve Calcification and Mild Tricuspid Regurgitation But No Clinical Heart Disease after 8 Years of Dopamine Agonist Therapy for Prolactinoma
- (2008) Marleen Kars et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
- (2008) B. M. K. Biller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
- (2008) M. Boscaro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
- (2008) Rosario Pivonello et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin and dopamine receptors as targets for medical treatment of Cushing’s Syndrome
- (2008) C. de Bruin et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Late Recurrences of Cushing’s Disease after Initial Successful Transsphenoidal Surgery
- (2007) Chirag G. Patil et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin and somatostatin receptors in Cushing's disease
- (2007) Leo J. Hofland MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started